Stanford University
Dr. Heather Wakelee is a Professor of Medicine and Chief of the Division of Oncology at Stanford University. She is the Deputy Director of the Stanford Cancer Institute. Dr. Wakelee has authored or co-authored over 200 medical articles on lung cancer and other thoracic malignancies and is involved in dozens of clinical trials related to lung cancer therapy and diagnostics. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF and others. She is also involved in trials of adjuvant therapy, immunotherapy and anti-angiogenesis agents in addition to collaborations with colleagues focused in biomarkers and others focused in population science research. Dr. Wakelee is active in multiple national and international lung cancer research organizations including serving as President of the International Association for the Study of Lung Cancer (IASLC), and as a Fellow of the American Society of Clinical Oncology (FASCO).
Session 2: Upfront Treatment in Sensitizing EGFR Mutation
Thursday, May 4, 2023
9:00 AM – 9:45 AM ET